This Article Full Text Full Text (PDF) All Versions of this Article: 37/5/1271    most recent 01.STR.0000217404.64352.d7v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, J. Articles by Saavedra, J. M. Search for Related Content PubMed PubMed Citation Articles by Zhou, J. Articles by Saavedra, J. M. Pubmed/NCBI databases GEO DataSet GEO Profiles Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Related Collections Cerebrovascular disease/stroke Carotid Stenosis Carotid endarterectomy Angioplasty and Stenting

(Stroke. 2006;37:1271.)
© 2006 American Heart Association, Inc.

Original Contributions

AT₁ Receptor Blockade Regulates the Local Angiotensin II System in Cerebral Microvessels From Spontaneously Hypertensive Rats

Jin Zhou, MD, PhD; Jaroslav Pavel, PhD; Miroslava Macova, PhD; Zu-Xi Yu, MD, PhD; Hans Imboden, PhD; Linna Ge, BSc; Tsuyoshi Nishioku, PhD; Jingtao Dou, MD, PhD; Elizabeth Delgiacco, BSc Juan M. Saavedra, MD

From the Section on Pharmacology (J.Z., J.P., M.M., L.G., T.N., J.D., E.D., J.M.S.), Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Md; Pathology Core (Z.-X.Y.), National Heart, Lung and Blood Institute, Bethesda, Md; and Institute of Cell Biology (H.I.), University of Bern, Bern, Switzerland.

Correspondence and reprint requests to Jin Zhou, MD, PhD, Section on Pharmacology, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA. E-mail jinzhou{at}mail.nih.gov

Background and Purpose— Blockade of angiotensin II AT₁ receptors in cerebral microvessels protects against brain ischemia and inflammation. In this study, we tried to clarify the presence and regulation of the local renin-angiotensin system (RAS) in brain microvessels in hypertension.

Methods— Spontaneously hypertensive rats (SHR) and Wistar Kyoto (WKY) controls were treated with an AT₁ receptor antagonist (candesartan, 0.3 mg/kg per day) via subcutaneous osmotic minipumps for 4 weeks. The expression and localization of RAS components and the effect of AT₁ receptor blockade were assessed by Affymetrix microarray, qRT-PCR, Western blots, immunohistochemistry and immunofluorescence.

Results— We found transcripts of most of RAS components in our microarray database, and confirmed their expression by qRT-PCR. Angiotensinogen (Aogen), angiotensin-converting enzyme (ACE) and AT₁ receptors were localized to the endothelium. There was no evidence of AT₂ receptor localization in the microvascular endothelium. In SHR, (pro)renin receptor mRNA and AT₁ receptor mRNA and protein expression were higher, whereas Aogen, ACE mRNA and AT₂ receptor mRNA and protein expression were lower than in WKY rats. Candesartan treatment increased Aogen, ACE and AT₂ receptor in SHR, and increased ACE and decreased Aogen in WKY rats, without affecting the (pro)renin and AT₁ receptors.

Conclusions— Increased (pro)renin and AT₁ receptor expression in SHR substantiates the importance of the local RAS overdrive in the cerebrovascular pathophysiology in hypertension. AT₁ receptor blockade and increased AT₂ receptor stimulation after administration of candesartan may contribute to the protection against brain ischemia and inflammation.

Key Words: circulation • endothelial cells • hypertension • renin-angiotensin system

This article has been cited by other articles:

				S. Chen, G. Li, W. Zhang, J. Wang, C. D. Sigmund, J. E. Olson, and Y. Chen Ischemia-induced brain damage is enhanced in human renin and angiotensinogen double-transgenic mice Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2009; 297(5): R1526 - R1531. [Abstract] [Full Text] [PDF]

				C. A. McCarthy, A. Vinh, J. K. Callaway, and R. E. Widdop Response to Letter by Tsuda Stroke, July 1, 2009; 40(7): e494 - e494. [Full Text] [PDF]

				M. White, H. Ross, S. Levesque, L. Whittom, G. B Pelletier, N. Racine, S. Meloche, and L. Voisin Effects of Angiotensin-Converting Enzyme Inhibitor Versus Valsartan on Cellular Signaling Events in Heart Transplant Ann. Pharmacother., May 1, 2009; 43(5): 831 - 839. [Abstract] [Full Text] [PDF]

				E. Sanchez-Lemus, J. Benicky, J. Pavel, I. M. Larrayoz, J. Zhou, M. Baliova, T. Nishioku, and J. M. Saavedra Angiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleen Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1376 - R1384. [Abstract] [Full Text] [PDF]

				C. A. McCarthy, A. Vinh, J. K. Callaway, and R. E. Widdop Angiotensin AT2 Receptor Stimulation Causes Neuroprotection in a Conscious Rat Model of Stroke * Supplemental Materials and Methods Stroke, April 1, 2009; 40(4): 1482 - 1489. [Abstract] [Full Text] [PDF]

				S. Inaba, M. Iwai, Y. Tomono, I. Senba, M. Furuno, H. Kanno, H. Okayama, M. Mogi, J. Higaki, and M. Horiuchi Exaggeration of Focal Cerebral Ischemia in Transgenic Mice Carrying Human Renin and Human Angiotensinogen Genes Stroke, February 1, 2009; 40(2): 597 - 603. [Abstract] [Full Text] [PDF]

				S. Inaba, M. Iwai, M. Furuno, Y. Tomono, H. Kanno, I. Senba, H. Okayama, M. Mogi, J. Higaki, and M. Horiuchi Continuous Activation of Renin-Angiotensin System Impairs Cognitive Function in Renin/Angiotensinogen Transgenic Mice Hypertension, February 1, 2009; 53(2): 356 - 362. [Abstract] [Full Text] [PDF]

				W. Kozak, A. Kozak, M. H. Johnson, H. F. Elewa, and S. C. Fagan Vascular Protection with Candesartan after Experimental Acute Stroke in Hypertensive Rats: A Dose-Response Study J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 773 - 782. [Abstract] [Full Text] [PDF]

				J. A. Phipps, J. L. Wilkinson-Berka, and E. L. Fletcher Retinal Dysfunction in Diabetic Ren-2 Rats Is Ameliorated by Treatment with Valsartan but Not Atenolol Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 927 - 934. [Abstract] [Full Text] [PDF]